EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtLeitlinieOpen Access · CC BY-NC 4.0

Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines

Banghyun Lee iD, Suk-Joon Chang iD, Byung Su Kwon iD, Joo-Hyuk Son iD, Myong Cheol Lim iD, Yun Hwan Kim iD, Shin-Wha Lee iD, Chel Hun Choi iD, Kyung Jin Eoh iD, Jung-Yun Lee iD, Dong Hoon Suh iD, Yong Beom Kim iD

Journal of Gynecologic Oncology · 2024 · 35 (1)

DOI: 10.3802/jgo.2024.35.e43 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Gynecologic Oncology, 2024. Verfasst von Banghyun Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Inha University Hospital, Inha University College of Medicine, Incheon, Korea. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Ovarian Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the latest practice guidelines for ovarian cancer were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2021, many studies have examined the efficacy and safety of various treatments for epithelial ovarian cancer (EOC). Therefore, the need to develop recommendations for EOC treatments has been raised. This study searched the literature using 4 key items and the Population, Intervention, Comparison, and Outcome: the efficacy and safety of poly-ADP ribose polymerase inhibitors in newly diagnosed advanced EOC; the efficacy and safety of intraperitoneal plus intravenous chemotherapy in optimally debulked advanced EOC; the efficacy and safety of secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer; and the efficacy and safety of the addition of bevacizumab to platinum-based chemotherapy in first platinum-sensitive recurrent EOC patients who received prior bevacizumab. The evidence for these recommendations, according to each key question, was evaluated using a systematic review and meta-analysis. The committee of ovarian cancer of the KSGO developed updated guidelines for treatments of EOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalOvarian NeoplasmsFemaleHumansBevacizumabCarcinoma, Ovarian EpithelialRepublic of Korea

Stichwörter der Autor:innen

BevacizumabCytoreductive SurgeryEpithelial Ovarian CancerIntraperitoneal ChemotherapyPoly (ADP-ribose) Polymerase InhibitorSurvival

Substanzen

Bevacizumab

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
  • Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. drchang@ajou.ac.kr.
  • Department of Obstetrics and Gynecology, Kyung Hee University Medical Center, School of Medicine, Kyung Hee University, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
  • Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.

ORCID-Profile: Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo-Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin-Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee, Dong Hoon Suh, Yong Beom Kim

Förderung

  • National Cancer Center

Zitieren

APA

Lee, B., Chang, S. J., Kwon, B. S., Son, J. H., Lim, M. C., Kim, Y. H., Lee, S. W., Choi, C. H., Eoh, K. J., Lee, J. Y., Suh, D. H., & Kim, Y. B. (2024). Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of Gynecologic Oncology, 35(1). https://doi.org/10.3802/jgo.2024.35.e43

Vancouver

Lee B, Chang SJ, Kwon BS, Son JH, Lim MC, Kim YH, et al. Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines. Journal of Gynecologic Oncology. 2024;35(1). doi:10.3802/jgo.2024.35.e43

BibTeX
@article{Lee2024,
  author = {Lee, Banghyun and Chang, Suk-Joon and Kwon, Byung Su and Son, Joo-Hyuk and Lim, Myong Cheol and Kim, Yun Hwan and Lee, Shin-Wha and Choi, Chel Hun and Eoh, Kyung Jin and Lee, Jung-Yun and Suh, Dong Hoon and Kim, Yong Beom},
  title = {Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines},
  journal = {Journal of Gynecologic Oncology},
  year = {2024},
  volume = {35},
  number = {1},
  doi = {10.3802/jgo.2024.35.e43}
}
Kostenlos starten →